Logo image of BSD2.DE

BANCO SANTANDER SA (BSD2.DE) Stock Fundamental Analysis

FRA:BSD2 - Deutsche Boerse Ag - ES0113900J37 - Common Stock - Currency: EUR

7.527  -0.09 (-1.16%)

Fundamental Rating

3

Taking everything into account, BSD2 scores 3 out of 10 in our fundamental rating. BSD2 was compared to 92 industry peers in the Banks industry. Both the profitability and financial health of BSD2 have multiple concerns. BSD2 has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year BSD2 was profitable.
In the past year BSD2 has reported a negative cash flow from operations.
Of the past 5 years BSD2 4 years were profitable.
BSD2 had a positive operating cash flow in 4 of the past 5 years.
BSD2.DE Yearly Net Income VS EBIT VS OCF VS FCFBSD2.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B -20B 40B 60B

1.2 Ratios

The Return On Assets of BSD2 (0.68%) is comparable to the rest of the industry.
Looking at the Return On Equity, with a value of 12.75%, BSD2 is in the better half of the industry, outperforming 64.13% of the companies in the same industry.
Industry RankSector Rank
ROA 0.68%
ROE 12.75%
ROIC N/A
ROA(3y)0.62%
ROA(5y)0.36%
ROE(3y)11.71%
ROE(5y)6.74%
ROIC(3y)N/A
ROIC(5y)N/A
BSD2.DE Yearly ROA, ROE, ROICBSD2.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

BSD2 has a worse Profit Margin (17.68%) than 61.96% of its industry peers.
BSD2's Profit Margin has improved in the last couple of years.
The Operating Margin and Gross Margin are not available for BSD2 so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 17.68%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y6.17%
PM growth 5Y10.55%
GM growth 3YN/A
GM growth 5YN/A
BSD2.DE Yearly Profit, Operating, Gross MarginsBSD2.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10

1

2. Health

2.1 Basic Checks

BSD2 does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for BSD2 has been reduced compared to 1 year ago.
Compared to 5 years ago, BSD2 has less shares outstanding
Compared to 1 year ago, BSD2 has a worse debt to assets ratio.
BSD2.DE Yearly Shares OutstandingBSD2.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B
BSD2.DE Yearly Total Debt VS Total AssetsBSD2.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500B 1T 1.5T

2.2 Solvency

BSD2 has a Debt/Equity ratio of 3.30. This is a high value indicating a heavy dependency on external financing.
BSD2 has a worse Debt to Equity ratio (3.30) than 71.74% of its industry peers.
Industry RankSector Rank
Debt/Equity 3.3
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC5.16%
BSD2.DE Yearly LT Debt VS Equity VS FCFBSD2.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100B 200B 300B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
BSD2.DE Yearly Current Assets VS Current LiabilitesBSD2.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

4

3. Growth

3.1 Past

BSD2 shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 20.90%, which is quite impressive.
The Earnings Per Share has been growing by 16.42% on average over the past years. This is quite good.
The Revenue has been growing slightly by 7.01% in the past year.
Measured over the past years, BSD2 shows a small growth in Revenue. The Revenue has been growing by 3.17% on average per year.
EPS 1Y (TTM)20.9%
EPS 3Y20.14%
EPS 5Y16.42%
EPS Q2Q%23.53%
Revenue 1Y (TTM)7.01%
Revenue growth 3Y8.95%
Revenue growth 5Y3.17%
Sales Q2Q%3.27%

3.2 Future

The Earnings Per Share is expected to grow by 4.18% on average over the next years.
The Revenue is expected to grow by 1.24% on average over the next years.
EPS Next Y9.57%
EPS Next 2Y9.52%
EPS Next 3Y10.59%
EPS Next 5Y4.18%
Revenue Next Year1.08%
Revenue Next 2Y1.77%
Revenue Next 3Y2.32%
Revenue Next 5Y1.24%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BSD2.DE Yearly Revenue VS EstimatesBSD2.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 20B 40B 60B
BSD2.DE Yearly EPS VS EstimatesBSD2.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.2 0.4 0.6 0.8 1

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 9.29, which indicates a very decent valuation of BSD2.
BSD2's Price/Earnings is on the same level as the industry average.
The average S&P500 Price/Earnings ratio is at 27.93. BSD2 is valued rather cheaply when compared to this.
Based on the Price/Forward Earnings ratio of 8.15, the valuation of BSD2 can be described as reasonable.
Based on the Price/Forward Earnings ratio, BSD2 is valued cheaper than 81.52% of the companies in the same industry.
BSD2 is valuated cheaply when we compare the Price/Forward Earnings ratio to 37.78, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 9.29
Fwd PE 8.15
BSD2.DE Price Earnings VS Forward Price EarningsBSD2.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BSD2.DE Per share dataBSD2.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6

4.3 Compensation for Growth

BSD2's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.97
PEG (5Y)0.57
EPS Next 2Y9.52%
EPS Next 3Y10.59%

3

5. Dividend

5.1 Amount

BSD2 has a Yearly Dividend Yield of 2.24%.
Compared to an average industry Dividend Yield of 5.01, BSD2's dividend is way lower than its industry peers. On top of this 88.04% of the companies listed in the same industry pay a better dividend than BSD2!
Compared to an average S&P500 Dividend Yield of 2.32, BSD2 has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.24%

5.2 History

The dividend of BSD2 decreases each year by -2.45%.
Dividend Growth(5Y)-2.45%
Div Incr Years3
Div Non Decr Years3
BSD2.DE Yearly Dividends per shareBSD2.DE Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 0.05 0.1 0.15 0.2

5.3 Sustainability

BSD2 pays out 23.99% of its income as dividend. This is a sustainable payout ratio.
DP23.99%
EPS Next 2Y9.52%
EPS Next 3Y10.59%
BSD2.DE Yearly Income VS Free CF VS DividendBSD2.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B -20B 40B
BSD2.DE Dividend Payout.BSD2.DE Dividend Payout, showing the Payout Ratio.BSD2.DE Dividend Payout.PayoutRetained Earnings

BANCO SANTANDER SA

FRA:BSD2 (7/28/2025, 7:00:00 PM)

7.527

-0.09 (-1.16%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)04-30 2025-04-30/bmo
Earnings (Next)07-30 2025-07-30/bmo
Inst Owners28.2%
Inst Owner ChangeN/A
Ins Owners0.47%
Ins Owner ChangeN/A
Market Cap111.90B
Analysts82.14
Price Target7.43 (-1.29%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.24%
Yearly Dividend0.19
Dividend Growth(5Y)-2.45%
DP23.99%
Div Incr Years3
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)21.36%
Min EPS beat(2)-0.99%
Max EPS beat(2)43.7%
EPS beat(4)2
Avg EPS beat(4)10.17%
Min EPS beat(4)-5.17%
Max EPS beat(4)43.7%
EPS beat(8)5
Avg EPS beat(8)7.54%
EPS beat(12)9
Avg EPS beat(12)6.29%
EPS beat(16)12
Avg EPS beat(16)5.18%
Revenue beat(2)1
Avg Revenue beat(2)0.28%
Min Revenue beat(2)-2.51%
Max Revenue beat(2)3.06%
Revenue beat(4)2
Avg Revenue beat(4)-0.03%
Min Revenue beat(4)-2.51%
Max Revenue beat(4)3.06%
Revenue beat(8)4
Avg Revenue beat(8)2.26%
Revenue beat(12)8
Avg Revenue beat(12)11.58%
Revenue beat(16)12
Avg Revenue beat(16)15.07%
PT rev (1m)0%
PT rev (3m)10.07%
EPS NQ rev (1m)0%
EPS NQ rev (3m)1.23%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.42%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.12%
Valuation
Industry RankSector Rank
PE 9.29
Fwd PE 8.15
P/S 1.57
P/FCF N/A
P/OCF N/A
P/B 1.13
P/tB 1.41
EV/EBITDA N/A
EPS(TTM)0.81
EY10.76%
EPS(NY)0.92
Fwd EY12.27%
FCF(TTM)-2.34
FCFYN/A
OCF(TTM)-1.62
OCFYN/A
SpS4.78
BVpS6.63
TBVpS5.34
PEG (NY)0.97
PEG (5Y)0.57
Profitability
Industry RankSector Rank
ROA 0.68%
ROE 12.75%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 17.68%
GM N/A
FCFM N/A
ROA(3y)0.62%
ROA(5y)0.36%
ROE(3y)11.71%
ROE(5y)6.74%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y6.17%
PM growth 5Y10.55%
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 3.3
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 321.74%
Cap/Sales 14.9%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score6
WACC5.16%
ROIC/WACCN/A
Cap/Depr(3y)371.12%
Cap/Depr(5y)366.07%
Cap/Sales(3y)17.82%
Cap/Sales(5y)18.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)20.9%
EPS 3Y20.14%
EPS 5Y16.42%
EPS Q2Q%23.53%
EPS Next Y9.57%
EPS Next 2Y9.52%
EPS Next 3Y10.59%
EPS Next 5Y4.18%
Revenue 1Y (TTM)7.01%
Revenue growth 3Y8.95%
Revenue growth 5Y3.17%
Sales Q2Q%3.27%
Revenue Next Year1.08%
Revenue Next 2Y1.77%
Revenue Next 3Y2.32%
Revenue Next 5Y1.24%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-302.79%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-581.65%
OCF growth 3YN/A
OCF growth 5YN/A